Prime Highlights: Aurobindo Pharma is using Europe as a major growth market, expanding its presence

Prime Highlights: Cellbyte secures $2.75 million in seed funding to develop an AI-driven platform for

Prime Highlights: Aptamer Group secures a £617,000 contractwith a top five global pharmaceutical company, marking

Prime Highlights: ImmuPharma is in talks with several major pharmaceutical companies, including some of the

Prime Highlights Alvotech and Advanz Pharma have secured European Commission approval for Gobivaz, the first

Prime Highlights: GSK has signed a $50 million deal with LTZ Therapeutics to develop new

Prime Highlights:  Glenmark Pharma’s Q2 profit jumped 72.2%, boosting investor confidence and lifting the stock during

Prime Highlight  Mursla Bio has partnered with a leading global pharmaceutical company to accelerate biomarker-guided drug development

Prime Highlights: Reacta Healthcare, based in North Wales, is expanding its global reach with two

Prime Highlights: The FDA has approved Innate Pharma’s Phase 3 trial for lacutamab in cutaneous

Prime Highlight: Omada Health will begin prescribing GLP-1s and other obesity medications as part of

Prime Highlights:  A dozen drugmakers are developing new weight-loss treatments that prioritize muscle mass preservation